Journal History
2013 | The inaugural issue was released. Vaccines was published as a quarterly journal. |
2015 | Vaccines was indexed in Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1). Vaccines was indexed in Scopus (Elsevier), starting with Volume 1 (Issue 1). Vaccines was indexed in PubMed—National Library of Medicine (NLM), starting with Volume 1 (Issue 1). |
2017 | Vaccines announced the first edition of the Travel Awards. The journal Twitter account was established. |
2018 | Vaccines was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics), starting with Volume 4 (Issue 1). |
2019 | Vaccines received its first Impact Factor (4.76). The journal ranks 39/158 (Q1) in the 'Immunology' category and 25/136 (Q1) in the "Medicine, Research & Experimental" category. |
2020 | Vaccines published its 1000th paper. Vaccines established the following sections: -Vaccine Adjuvants; -Attenuated/Inactivated/Live and Vectored Vaccines; -Clinical Immunology; -Cellular/Molecular Immunology; -Pathogens-host Immune Interface; -Human Papillomavirus Vaccines; -Hepatitis Virus Vaccines. |
2021 | Vaccines established the following sections: -COVID-19 Vaccines and Vaccination; -Vaccination Optimization; -DNA and mRNA Vaccines. |
2023 | The year 2023 marked the 10th Anniversary of Vaccines. |
Editor-in-Chief
2013–2019 | Editor-in-Chief: Prof. Dr. Diane M. Harper |
2019–present | Editor-in-Chief: Prof. Dr. Ralph A. Tripp |
Section Editor-in-Chief
2019–present | Section Editor-in-Chief: Dr. Subbaya Subramanian for the section on Cancer Vaccines and Immunotherapy |
Section Editor-in-Chief: Dr. Romain Paillot for the section on Veterinary Vaccines | |
Section Editor-in-Chief: Prof. Dr. Giuseppe La Torre for the section on Epidemiology | |
Section Editor-in-Chief: Prof. Dr. Nirbhay Kumar for the section on Vaccines against (re)emerging and Tropical Infections Diseases | |
Section Editor-in-Chief: Prof. Dr. Martin F. Bachmann for the section on Therapeutic Vaccines and Antibody Therapeutics | |
2020–present | Section Editor-in-Chief: Dr. Yee-Joo Tan for the section on Hepatitis Virus Vaccines |
Section Editor-in-Chief: Prof. Dr. François Meurens for the section on Pathogens-host Immune Interface | |
Section Editor-in-Chief: Prof. Dr. Hans-Peter Hartung for the section on Cellular/Molecular Immunology | |
Section Editor-in-Chief: Dr. Eduardo Gomez-Casado for the section on Vaccine Adjuvants | |
Section Editor-in-Chief: Prof. Dr. Giampiero Girolomoni for the section on Clinical Immunology | |
Section Editor-in-Chief: Prof. Dr. Nirbhay Kumar for the section on HIV Vaccines | |
2021–present | Section Editor-in-Chief: Prof. Dr. Luis Martinez-Sobrido for the section on COVID-19 Vaccines and Vaccination |
Section Editor-in-Chief: Prof. Dr. Hinh Ly for the section on Innate and Adaptive Immunity in Vaccination | |
Section Editor-in-Chief: Prof. Dr. Jorge H. Leitão for the section on DNA and mRNA Vaccines | |
Section Editor-in-Chief: Prof. Dr. Amine A. Kamen for the section on Attenuated/Inactivated/Live and Vectored Vaccines | |
2021–2023 | Section Editor-in-Chief: Dr. Ralph J. DiClemente for the section on Vaccines and Society |
2023–present | Section Editor-in-Chief: Dr. Pedro Plans-Rubió for the section on Vaccine Efficacy and Safety |